nprnews_____ = ||| lubuntu at wor2 670N|||20 Million Africans Are Due For Their 2nd COVID Shot. But There's No Supply In Sight||| kickerpage = |||no kicker pagenpr for NPRNEWS||| summarynpr = |||African nations had been counting on Serum Institute of India for nearly all their COVID vaccines. Now the company says it won't be sending any more for months. And African officials are scrambling.

class="imagewrap has-source-dimensions"
data-crop-type="wide"
style="
--source-width: 4000;
--source-height: 2250;
"
>

An older person receives their first dose of the AstraZeneca vaccine in Thika, Kenya. The vaccine's manufacturer, Serum Institute of India, announced this week that it will freeze all exports of the vaccine through the end of this year — leaving 20 million people in Africa without a source for their second dose.



Patrick Meinhardt/Bloomberg via Getty Images


hide caption

toggle caption

Patrick Meinhardt/Bloomberg via Getty Images

Goats and Soda

20 Million Africans Are Due For Their 2nd COVID Shot. But There's No Supply In Sight

African nations had been counting on Serum Institute of India for nearly all their COVID vaccines. Now the company says it won't be sending any more for months. And African officials are scrambling.